CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
2.48
-0.27 (-9.82%)
At close: Jun 16, 2025, 3:59 PM
2.49
0.61%
Pre-market: Jun 17, 2025, 06:45 AM EDT
CytomX Therapeutics Revenue
CytomX Therapeutics reported an annual revenue of $138.1M, reflecting a 36.45% growth. For the quarter ending March 31, 2025, CytomX Therapeutics generated $50.92M in revenue.
Revenue (ttm)
$138.1M
Revenue Growth
36.45%
Price / Sales Ratio
0.63
Revenue / Employee
$1.16M
Employees
119
Market Cap
389.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|